This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The FDA has created an emergency program to accelerate the development of treatments...
San Diego biotech MEI Pharma has upped its pact with Tokyo, Japan-based Kyowa Kirin...
The U.S. Biomedical Advanced Research and Development Authority has rejected Pluristem...